Ledger.Open graph →
SEC Form D · Amendment · filed September 30, 2015

Lung Therapeutics, Inc

Offering
$2.6M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Aaron B. Fletcher · Carrollton, TXDirectorJoseph B. Woelkers · Tyler, TXDirectorJames B. Windsor · Austin, TXExec · DirectorRobert B. Mills · Naples, FLDirectorSteven B. Idell · Tyler, TXDirectorHamish Cameron · London, United KingdomDirectorCatherine Bingham · London, United KingdomDirectorKathryn Stewart · LARKSPUR, CADirectorSusan L. Preston · Newcastle, WADirectorMichael Ross · London, United KingdomExec · DirectorJeff Levine · Greenwood Village, CODirectorMark Schulman · Greenwood Village, CODirectorTimothy Chklovski · Los Angeles, CADirectorAlberto Siblesz · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗